Smart Search
Share Results
| COMPANY | SYMBOL | TYPE | PRICE | Shares | Trade Date | UNDERWRITER (S) |
| Acceleron Pharma | XLRN | IPO | $13.00-$15.00 | 5.6 million | 9/19/2013 | Citigroup, Leerink Swann, Piper Jaffray |
| Ambit Biosciences Corporation | AMBI | IPO | $8.00-$8.00 | 8.1 million | 5/16/2013 | Citigroup, Leerink Swann |
| Cempra Holdings | CEMP | IPO | $11.00-$13.00 | 6 million | 2/3/2012 | Stifel Nicolaus Weisel, Leerink Swann, Cowen and Company |
| Dicerna Pharmaceuticals, Inc. | DRNA | IPO | $11.00-$13.00 | 6 million | 1/30/2014 | Jefferies, Leerink Swann, Stifel |
| Eleven Biotherapeutics | EBIO | IPO | $13.00-$15.00 | 5 million | 2/6/2014 | Citigroup, Cowen & Co., Leerink Swann |
| KaloBios Pharmaceuticals | KBIO | IPO | $12.00-$14.00 | 8.75 million | 1/31/2013 | Leerink Swann |
| MacroGenics, Inc. | MGNX | IPO | $14.00-$16.00 | 5 million | 10/10/2013 | BofA Merrill Lynch, Leerink Swann |
| Omthera Pharmaceuticals | OMTH | IPO | $12.00-$14.00 | 8 million | 4/11/2013 | BofA Merrill Lynch, Barclays Capital, Leerink Swann |
| OncoMed Pharmaceuticals | OMED | IPO | $14.00-$16.00 | 4.8 million | 7/18/2013 | Jefferies, Leerink Swann |
| Onconova Therapeutics | ONTX | IPO | $12.00-$14.00 | 5.2 million | 7/25/2013 | Citigroup, Leerink Swann |
| Paratek Pharmaceuticals, Inc. | PRTK | IPO | TBD | TBD | 0/0/0 | UBS Investment Bank, Leerink Swann |
| Prosensa Holding B.V. | RNA | IPO | $11.00-$13.00 | 6 million | 6/28/2013 | J.P. Morgan, Citigroup, Leerink Swann |
| Receptos | RCPT | IPO | $14.00-$16.00 | 5.2 million | 5/9/2013 | Credit Suisse, Leerink Swann, BMO Capital Markets |
| Tesaro | TSRO | IPO | $12.00-$15.00 | 6.0 million | 6/28/2014 | Citigroup, Morgan Stanley, Leerink Swann |
| uniQure B.V. | QURE | IPO | $13.00-$15.00 | 5.4 million | 2/5/2014 | Jefferies, Leerink Swann, Piper Jaffray |
| Veracyte, Inc. | VCYT | IPO | $13.00-$15.00 | 5 million | 10/30/2013 | Morgan Stanley, Leerink Swann |
| Verastem, Inc. | VSTM | IPO | $9.00-$11.00 | 5.5 million | 1/27/2012 | Jefferies, Leerink Swann |
| Xencor | XNCR | IPO | Priced at $5.50 | 12.7 million | 12/3/2013 | Credit Suisse, Leerink Swann, Wedbush PacGrow Life Sciences |
IPO Boutique advisories are available with your choice of a monthly or annual payment.
To subscribe to IPO Boutique click:
© 2005 - 2024 IPO Boutique. All Rights Reserved